Skip to Content

News: Breast Cancer

Study explores how some breast cancers resist treatment

Thursday, April 21st, 2016

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies. The new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified gene alterations […]

Switching breast cancer off

Thursday, April 14th, 2016

Receptor tyrosine kinases (RTKs) – key regulators of cell signaling pathways – are commonly implicated in the proliferation of malignant tumors. The EPHA2 RTK is overexpressed in aggressive forms of breast cancer, and this overexpression correlates with poor patient outcomes. EPHA2 is believed to operate somewhat like a switch: when its ligand, ephrin-A1, is present, […]

T.J. Martell Foundation lauds Pietenpol’s research

Thursday, March 17th, 2016

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. The Medical Research Advancement Award is in recognition of Pietenpol’s career as a cancer researcher. […]

Annual Pink Out women’s basketball game set for Feb. 14

Thursday, February 11th, 2016

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer. Pink is the color associated with breast cancer research and survivorship, so the Commodores will wear special uniforms during the matchup against the […]

VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’

Thursday, December 10th, 2015

Justin Balko, Pharm.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been named a member of the 2016 class of Pink Tie Guys by the Greater Nashville Affiliate of Susan G. Komen, a nonprofit organization dedicated to breast cancer research and patient support. The Pink Tie Guys are community leaders in the corporate, philanthropy, […]

Study shows compression device helps ease lymphedema

Friday, October 9th, 2015

Lymphedema patients saw a nearly 80 percent reduction in cellulitis episodes by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing’s Sheila Ridner, Ph.D., and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, Ph.D. The reduction in episodes also led […]

Komen, VICC partnership bolsters breast cancer research

Friday, October 9th, 2015

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Komen has provided more […]

VICC investigators land Komen breast cancer grants

Thursday, October 1st, 2015

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. The 2015 grants will provide nearly […]

Team to explore using nanoparticles to fight cancer

Thursday, September 24th, 2015

Three Vanderbilt researchers have received a federal grant to study the use of nanoparticles to deliver potential therapies for breast cancer that has spread to the bone. The grant from the Department of Defense Breast Cancer Research Program will provide more than $700,000 over three years in support of the research spearheaded by Julie Sterling, […]

Arteaga lauded for cancer research contributions

Thursday, August 27th, 2015

Carlos L. Arteaga, M.D., the Donna S. Hall Professor of Breast Cancer and director of the Center for Cancer Targeted Therapies and the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been recognized for his cancer research efforts by the American-Italian Cancer Foundation (AICF). The AICF will also honor Frederick Alt, Ph.D., a Howard […]

Next Page »« Previous Page